ReviewFrontiers in pharmacology2025

Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease.

Wei Xuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.